CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
Seungah Lee, Dong Yun Lee
Ann Pediatr Endocrinol Metab. 2017;22(1):15-26.   Published online March 31, 2017
DOI: https://doi.org/10.6065/apem.2017.22.1.15

Excel Download

Glucagon-like peptide-1 receptor agonists
Handbook of Incretin-based Therapies in Type 2 Diabetes. 2016;31-43   Crossref logo
Link1

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
Annals of Pediatric Endocrinology & Metabolism. 2017;22(1):15   Crossref logo
Link1 Link2 Link3

Treatment Strategy for Type 2 Diabetes with Obesity: Focus on Glucagon-like Peptide-1 Receptor Agonists
Clinical Therapeutics. 2017;39(6):1244-1264   Crossref logo
Link1 Link2

Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
Diabetes Spectrum. 2017;30(3):202-210   Crossref logo
Link1

Glucagon-like peptide-1 receptor agonists for type 2 diabetes: A rational drug development
Journal of Diabetes Investigation. 2018;10(2):196-201   Crossref logo
Link1 Link2

WITHDRAWN: Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
Canadian Journal of Diabetes. 2017;   Crossref logo
Link1 Link2

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
Diabetes mellitus. 2017;20(4):286-298   Crossref logo
Link1 Link2

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
The Journal of Korean Diabetes. 2018;19(1):35   Crossref logo
Link1 Link2 Link3

Glucagon-like Peptide-1 Receptor Agonists: A Class Update for Treating Type 2 Diabetes
Canadian Journal of Diabetes. 2017;41(5):524-535   Crossref logo
Link1 Link2

Glucagon-like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: a clinical perspective
Diabetes, Obesity and Metabolism. 2014;17(4):335-342   Crossref logo
Link1 Link2